#Asia-Pacific Cannabis Market Global Opportunity Analysis

[dtgmarketreport]

Global Medical Cannabis Market

 Market Overview

The global medical cannabis market is experiencing significant growth, with projections indicating a substantial increase in market size from USD 21.4 Billion in 2024 to USD 224.0 Billion by 2035. This represents a compound annual growth rate (CAGR) of approximately 23.8% between 2025 and 2035.

Key Market Segments

Products: Dried flowers, oils, tinctures, capsules, and topicals

Applications: Chronic pain, epilepsy, anxiety, and cancer-related conditions

Market Dynamics

Growth Drivers

Increasing Legalization: More countries are legalizing medical cannabis, expanding the global market.

Growing Awareness: Rising recognition of cannabis’s therapeutic benefits is driving adoption.

Advancements in Cannabis Science: Ongoing research is leading to new and improved cannabis-based products.

Chronic Disease Prevalence: The increasing incidence of chronic conditions is boosting demand for alternative treatments.

Challenges

Regulatory Hurdles: Strict and often inconsistent regulations across different countries hinder market growth.

International Trade Barriers: Cannabis’s classification as a scheduled narcotic impedes global trade and investment.

Limited Patient Access: In some regions, medical cannabis is only legal for specific conditions, limiting the potential market size.

Opportunities

Emerging Markets: Countries in Asia-Pacific, Latin America, and Africa are gradually implementing cannabis liberalization laws.

Advanced Formulations: Innovations in delivery methods and formulations (e.g., slow-release capsules, nanoemulsions) are improving efficacy and patient acceptance.

Customized Treatments: Development of condition-specific products (e.g., CBD-dominant for anxiety, THC-high for chronic pain) is expanding treatment options.

Get a free sample report @ https://www.metatechinsights.com/request-sample/1556

Regional Analysis

North America

Largest market due to early legalization and well-established regulatory frameworks

Key players: United States and Canada

Driven by advanced research, sophisticated cultivation techniques, and strong market presence

Asia-Pacific

Fastest-growing market

Key countries: Australia, Thailand, and New Zealand

Growth factors: Increasing awareness, favorable legal changes, and government support for research and production

Competitive Landscape

The market is fragmented, with a mix of established pharmaceutical companies and specialized cannabis firms. Key players include:

Canopy Growth Corporation

Aurora Cannabis Inc.

Tilray, Inc.

GW Pharmaceuticals

Cronos Group Inc.

Recent Developments

September 2024: Tilray partnered with a European pharmaceutical firm to supply medical cannabis products to the European market.

August 2024: Canopy Growth launched a new cannabis-based prescription drug for chronic pain in the United States.

Future Outlook

The medical cannabis market is poised for substantial growth, driven by increasing legalization, growing acceptance of cannabis as a therapeutic option, and ongoing research into its medical applications. However, the industry must navigate complex regulatory landscapes and overcome persistent stigma to reach its full potential. As the market matures, we can expect to see more standardized products, increased involvement from traditional pharmaceutical companies, and a growing body of clinical evidence supporting the efficacy of medical cannabis for various conditions.

[adhk1234]

Legal Marijuana Market Growth Drivers and Challenges

The global legal marijuana market is experiencing significant expansion, driven by increasing legalization and acceptance of cannabis for both medical and recreational purposes. Valued at USD 21.08 billion in 2023, the market is projected to reach USD 130.55 billion by 2031, exhibiting a compound annual growth rate (CAGR) of 25.6% from 2024 to 2031.

Market Segmentation:

The legal marijuana market is categorized based on type, product, and application:

By Type:

Medical: Utilized for treating various ailments such as chronic pain, neurological disorders, and cancer-related symptoms.

Recreational: Used for personal enjoyment and relaxation.

By Product:

Buds: The flowering part of the cannabis plant, commonly consumed by smoking or vaporizing.

Oils: Concentrated extracts used in edibles, tinctures, and topical applications.

Tinctures: Alcohol-based cannabis extracts consumed sublingually for rapid absorption.

By Application:

Chronic Pain: Cannabis is increasingly used to alleviate persistent pain conditions.

Neurological Disorders: Conditions such as epilepsy and multiple sclerosis are managed using medical marijuana.

Cancer: Helps in mitigating chemotherapy-induced nausea and improving appetite.

Others: Includes applications in mental health and gastrointestinal disorders.

Get Free Sample Report @ https://www.snsinsider.com/sample-request/1046

Regional Analysis:

North America: Leading the market due to widespread legalization and a well-established cannabis industry.

Europe: Experiencing growth with increasing medical cannabis approvals and progressive regulatory changes.

Asia-Pacific: Emerging market with gradual legalization and rising awareness of medical marijuana benefits.

Latin America: Notable growth driven by countries like Uruguay and Colombia embracing cannabis legalization.

Middle East & Africa: Slow adoption due to stringent regulations, but potential exists with ongoing legislative reviews.

Key Players

Key Service Providers/Manufacturers

Canopy Growth Corporation (Tweed, Spectrum Cannabis)

Aurora Cannabis Inc. (Aurora Sky, Aurora Drift)

Cronos Group (Peace Naturals, COVE)

Tilray, Inc. (Tilray, Aphria)

Hexo Corp. (Hexo, Redecan)

Charlotte's Web Holdings, Inc. (Charlotte's Web Hemp Extract, CBD Capsules)

Organigram Holdings Inc. (Organigram, Edison Cannabis Co.)

GW Pharmaceuticals (Epidiolex, Sativex)

Green Thumb Industries (Rythm, Dogwalkers)

Trulieve (Trulieve Cannabis, Muse)

Key Highlights:

Growing recognition of medical marijuana's therapeutic benefits is a primary market driver.

Legalization in various countries is creating new opportunities for industry stakeholders.

Development of diverse cannabis-based products caters to a broad spectrum of consumer preferences.

Challenges include navigating complex regulatory frameworks and addressing societal stigmas.

Future Outlook:

The legal marijuana market is poised for substantial growth as more countries move towards legalization and acceptance of cannabis. Advancements in research are expected to uncover new therapeutic applications, further driving demand. Additionally, the development of innovative consumption methods and products will attract a wider consumer base. However, companies must remain vigilant in navigating evolving regulations and ensuring product quality to maintain consumer trust.

Conclusion:

The global legal marijuana market is on a robust growth trajectory, offering significant opportunities for investors, healthcare providers, and consumers. As societal attitudes shift and legal frameworks evolve, the market is expected to expand, delivering economic benefits and novel therapeutic options.

Contact Us: Jagney Dave - Vice President of Client Engagement Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)

Other Related Reports:

Digital PCR-dPCR Market Size

Electronic Medical Record (EMR) Systems Market Size

3D Printing Medical Devices Market Size

[technostat]

Flow Battery Market Size, Industry Analysis, Business Prospect and Outlook

The global flow battery market is navigating a complex landscape of challenges and opportunities as demand for long-duration energy storage solutions continues to rise. Industry experts project market growth to exceed $1.2 billion by 2028, despite facing several technical and commercial hurdles.

Get Free Sample Report PDF @ https://www.econmarketresearch.com/request-sample/EMR00623

Market challenges center around high initial capital costs and system complexity compared to traditional battery technologies. "The flow battery industry is working diligently to address cost concerns through material innovations and manufacturing optimization," states Dr. Sarah Reynolds, Chief Technology Officer at Energy Storage Solutions Inc. "While upfront investments remain significant, the long lifecycle and minimal degradation characteristics of flow batteries provide compelling total cost of ownership advantages."

Technical challenges include improving energy density and reducing system footprint, particularly for urban installations. However, recent breakthroughs in electrolyte chemistry and membrane technology are showing promising results in addressing these limitations.

Market Segmentation:

By Type

Redox

Hybrid

By Material

Vanadium

Zinc Bromine

Iron

Others

By Storage

Large Scale

Small Scale

By Application

Grid/Utility

Commercial & Industrial

EV Charging Stations

Residential

By Geography

North America (USA, and Canada)

Europe (UK, Germany, France, Italy, Spain, Russia and Rest of Europe)

Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)

Latin America (Brazil, Mexico, and Rest of Latin America)

Middle East & Africa (South Africa, GCC, and Rest of Middle East & Africa)

Despite these obstacles, significant market opportunities are emerging. The increasing integration of renewable energy sources into power grids has created strong demand for long-duration storage solutions, where flow batteries excel. Their ability to provide storage durations of 6-12 hours or more positions them ideally for grid stabilization and renewable energy time-shifting applications.

Additional opportunities arise from the growing micro grid market, particularly in remote and island communities. Flow batteries' long cycle life and deep discharge capabilities make them well-suited for these applications, where maintenance requirements and replacement costs are critical considerations.

The industrial sector presents another expanding market, with manufacturers seeking reliable backup power solutions that can operate for extended periods. Flow batteries' scalability and non-flammable chemistry provide advantages over traditional lithium-ion systems in these applications.

Environmental considerations are also driving market growth, as flow batteries typically use more environmentally friendly materials than conventional batteries and offer easier recycling at end-of-life.

Our Related Report:

Poultry Vaccines Market Business Artificial Intelligence in Healthcare Market Business Artificial Intelligence in Medical Imaging Market Business Self-Healing Concrete Market Business CBD Oil Market Business SCADA Market Business Industrial Automation Market Business Medical Cannabis Market Business Industrial Wastewater Treatment Market Business Pharma E-Commerce Market Business

About Us:

Econ Market Research is a leading provider of comprehensive market intelligence, offering expert analysis and insights across a diverse range of industries. With a team of seasoned analysts and industry experts, we deliver high-quality market research reports, customized research solutions, and consulting services tailored to our clients' specific needs. Our commitment to quality, accuracy, and client satisfaction sets us apart, making us a trusted partner for businesses seeking actionable intelligence to navigate the complexities of today's global markets.

To find out more, visit https://www.econmarketresearch.com / or follow us on Twitter, Instagram, Facebook and LinkedIn.

Contact Us:

For inquiries, partnerships, or to learn more about our services, please contact us at Sales@econmarketresearch.com

[hellohappylyfe]

The Rising Popularity of CBD Gummies: Trends and Market Analysis

In recent years, the cannabis industry has witnessed a significant shift towards cannabidiol (CBD) products, particularly CBD gummies. These chewable, fruit-flavored treats have captured the attention of consumers seeking relief from anxiety, stress, and sleep disorders. This blog post explores the rising popularity of CBD gummies, market trends, and analysis.

What are CBD Gummies?

CBD gummies are edible products infused with CBD, a non-psychoactive compound derived from the hemp plant. They come in various shapes, sizes, and flavors, making them appealing to consumers. CBD gummies typically contain 5-20mg of CBD per serving and are often marketed as supplements for overall wellness.

Key Drivers of the CBD Gummy Market

Growing Demand for Natural Remedies: Consumers are increasingly seeking natural alternatives to pharmaceuticals, driving demand for CBD products.

Increased Accessibility: Relaxation of laws and regulations surrounding CBD has made it easier for manufacturers to produce and distribute CBD gummies.

Rising Awareness of CBD Benefits: Research highlighting CBD's potential health benefits has fueled consumer interest.

Market Trends

Diversification of Products: Manufacturers are introducing new flavors, shapes, and CBD concentrations to cater to diverse consumer preferences.

Targeted Marketing: Companies are focusing on specific demographics, such as athletes, seniors, and pet owners.

E-commerce Expansion: Online platforms have made CBD gummies accessible to a broader audience.

Benefits of CBD Gummies

Stress Relief: CBD's anxiolytic properties make gummies an attractive option for those seeking relaxation.

Improved Sleep: CBD's ability to regulate sleep patterns has led to increased adoption.

Pain Management: CBD's anti-inflammatory properties make gummies a popular choice for pain relief.

Challenges and Opportunities

Regulatory Uncertainty: Evolving laws and regulations pose challenges for manufacturers.

Quality Control: Ensuring consistent quality and potency remains a concern.

Expansion into New Markets: Emerging markets, such as Asia-Pacific, offer significant growth opportunities.

Market Analysis

The global CBD gummy market is projected to reach $13.9 billion by 2025, growing at a CAGR of 27.5%. Key players include:

Charlotte's Web

CVS Health

Medterra

Regional Insights

The United States dominates the CBD gummy market, followed by Europe. However, emerging markets like Thailand are showing promise, with increasing demand for CBD products, including CBD gummies in Thailand. 

Conclusion

The CBD gummy market is experiencing rapid growth, driven by consumer demand for natural remedies and increased accessibility. As the market evolves, manufacturers must navigate regulatory challenges and prioritize quality control. With expanding distribution channels and emerging markets, the future of CBD gummies looks promising. 

Source URL: https://sites.google.com/view/popularity-of-cbd-gummies/home

[savibangar]

CBD-infused Products Market to Reach $291.39 Billion by 2031

Meticulous Research®, a leading global market research firm, has released a detailed report titled “CBD-infused Products Market—Global Opportunity Analysis and Industry Forecast (2024-2031).” This report forecasts that the CBD-infused products market is expected to reach an impressive $291.39 billion by 2031, growing at a compound annual growth rate (CAGR) of 30.6% from 2024 to 2031.

Download Research Report Sample @ https://www.meticulousresearch.com/download-sample-report/cp_id=5184

The significant growth of the CBD-infused products market is driven by several factors. The increasing demand for and legalization of cannabis, coupled with a rising interest in cannabis-infused edibles, plays a crucial role in market expansion. Additionally, the therapeutic health benefits associated with CBD-infused products are attracting more consumers. However, challenges remain, particularly the high cost of cannabidiol (CBD) and stringent government regulations concerning cannabis use in certain regions.

Another area of potential growth is the increasing demand for CBD-infused products in pet food, along with the rising popularity of cannabis-infused beverages. These segments present significant opportunities for market stakeholders looking to innovate and expand their offerings.

The competitive landscape of the CBD-infused products market is moderately crowded, featuring a mix of large, medium, and small players from global, regional, and local markets. Key companies in this sector include Canopy Growth Corporation, Aurora Cannabis Inc., and Tilray Brands, all based in Canada, as well as U.S. firms such as Cresco Labs, MariMed Inc., and Irwin Naturals Inc. Other notable players include GW Pharmaceuticals (U.K.), Elixinol Global Limited (Australia), and various companies from India and Europe.

The market is segmented based on source, type, and distribution channel. Among the sources analyzed, the hemp segment is expected to dominate, accounting for approximately 76.3% of the market in 2024. The preference for hemp-sourced CBD products is driven by their lower tetrahydrocannabinol (THC) concentrations, which eliminate psychoactive effects, making them suitable for a wide range of medical applications. Moreover, the anti-inflammatory and antioxidant properties of hemp-derived CBD contribute to its popularity.

Browse in depth @  https://www.meticulousresearch.com/product/cbd-infused-products-market-5184

Within the types of products, the edibles segment is projected to hold a substantial share of 33.6% in 2024. The growing trend of cannabis for recreational use, alongside increasing demand for cannabis-infused foods, significantly boosts this segment. Factors contributing to its growth include the expanding use of CBD in confectionery and bakery products, as well as a growing consumer base seeking alternatives to smoking.

Regarding distribution channels, the offline segment is anticipated to lead the market due to consumer preferences for in-person shopping experiences. This preference is fueled by the desire for authentic and high-quality products, as well as the enhanced shopping experience that physical stores provide.

Geographically, the report offers a comprehensive analysis of various regions, including North America (U.S. and Canada), Europe (Germany, France, U.K., Spain, Italy, and others), Asia-Pacific (Australia, China, India, Japan, and others), Latin America (Mexico, Brazil, Argentina, and others), and the Middle East & Africa (GCC, Israel, South Africa, and others).

North America is expected to dominate the market, holding a 59.5% share in 2024, valued at approximately $26.76 billion. This dominance is attributed to factors such as accessibility, technological advancements in CBD production, a large consumer base, and a growing shift towards CBD for both medical and recreational use. Increased consumer awareness of the health benefits of CBD and rising spending on these products further solidify North America’s leading position in the CBD-infused products market.

Request Customization Report @ https://www.meticulousresearch.com/request-customization/cp_id=5184

[umadeochake]

Hydroponic Substrate Market Supply and Manufacturers Analysis Research Report 2036

Research Nester published a report titled “Hydroponic Substrate Market: Demand Analysis & Opportunity Outlook 2036” which delivers detailed overview of the global hydroponic substrate market in terms of market segmentation by type, and by region.

Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.

The global hydroponic substrate market is anticipated to grow with a CAGR of ~11% during the forecast period, i.e. 2023-2035. The market is segmented by type into organic and inorganic. Out of these, the inorganic segment is anticipated to garner the highest market share by 2031. The growth of the segment is attributed to high trade of rock wool which is a type of inorganic hydroponic substrate. The Observatory of Economic Complexity stated that in 2020, in 2020, rock wool was the world's 521st most traded product. This was equivalent to the value of USD 4.38 billion.

Request Free Sample Copy of this Report @ https://www.researchnester.com/sample-request-4322

The global hydroponic substrate market is estimated to garner a notable revenue by the end of 2031. Hydroponics farming is a preferred choice for its faster plant growth as compared to the conventional method. Also, it eliminates the need for pesticides and herbicides and any type of water can be used that can be recycled and reused, which further reduces the need for fresh water and uses less space. The recent health awareness has propelled the population to shift towards salad crops and vegetables which is expected to boost the growth of the hydroponics market during the forecast period. Furthermore, a higher yield of hydroponic crops as compared to conventional soil crops, increasing need for food security with increasing population, rising cultivation of medicinal plants, and increasing adoption of environment-friendly techniques such as farming, agriculture is some of the growth drivers of the hydroponics market.

Geographically, the global hydroponic substrate is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Out of these, the market in Asia Pacific region is estimate to garner the largest market share by the end of 2031, on the back of increased demand of food grains by burgeoning population, expansion in agricultural employment, high disposable income and considerable growth in GDP.

The research is global in nature and covers detailed analysis on the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players’ competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the research report.

Request for customization @ https://www.researchnester.com/customized-reports-4322

Rise in Agriculture Industry to Drive the Market Growth

This high growth rate is attributed to the adoption of hydroponic systems for the indoor farming of vegetables. Also, the rising preference of alternative farming methods for cannabis cultivation is rapidly rising, owing to the legalization of marijuana in many countries. The negative effects of pesticides and artificial ripening agents on their health is expected to drive the demand for hydroponics, as the method eliminates the need for such products, thereby providing nutritionally superior vegetables. Low installation cost and ease of operation of these systems are also expected to boost the adoption in near future.

However, the shortage of labors coupled with low adoption rate and additional expenses in production process is expected to operate as key restraints to the growth of the global hydroponic substrate over the forecast period.

This report also provides the existing competitive scenario of some of the key players of the global hydroponic substrate market which includes company profiling of Comercial Projar, S.A. (Projar Group), ROCKWOOL International A/S, Galuku Group Limited, CANNA, Ceyhinz Link International, Inc., JB Hydroponics B.V., The Wonderful Soils Company, Hydrofarm Holdings Group, Inc., Re-Nuble, Inc., Malaysia Hydroponics, and others. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global hydroponic substrate market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.     

Access our detailed report @ https://www.researchnester.com/reports/hydroponic-substrate-market/4322

About Research Nester-

Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties.

Contact for more Info:

AJ Daniel

Email: info@researchnester.com

U.S. Phone: +1 646 586 9123

U.K. Phone: +44 203 608 5919

[industryforecastnews]

Drug Testing Market Size To Reach USD 8.45 Billion By 2030

Drug Testing Market Growth & Trends

The global drug testing market size is expected to reach USD 8.45 billion by 2030, expanding at a CAGR of 4.8% from 2024 to 2030, according to a new report by Grand View Research, Inc.. The introduction of innovative tests, stringent regulation mandating drug testing, and growing substance abuse & addiction are some of the factors anticipated to foster market growth during the forecast period. 

Drug abuse and addiction is a global problem, affecting millions of people. As per the World Drug Report published by UNODC, in 2019, around 35.0 million people were suffering from drug use disorders globally. Such a high rate of drug abuse and substance use disorders has created a major demand for innovative tests to prevent, treat, and manage such cases. Several key players operating in this space are introducing innovative and efficient products to meet this growing demand.

For instance, in June 2019, Quidel Corporation received the U.S. FDA’s 510(k) clearance to market its fluorescence immunoassay—Quidel Triage TOX Drug Screen, 94600. This is intended for detecting the presence of metabolites or drugs in urine. Moreover, in June 2020, Cordant Health Solutions offered video-observed oral fluid drug testing to help courts & government agencies to monitor participants during the COVID-19 pandemic. This aided in combating several challenges faced by people with substance abuse disorders during the pandemic.

Continuous government initiatives and implementation of strict substance abuse testing regulations to ensure safety have derived the demand for its testing products. In July 2020, the New Zealand government introduced a new bill that provides police the power to conduct random roadside drug testing of drivers to reduce impaired driving in the country. The new bill allows usage of oral fluid tests to check drivers for substances such as cocaine, ecstasy, cannabis, opiates, methamphetamine, and benzodiazepines. Also, in February 2020, the Directorate General of Civil Aviation in India introduced extensive tests for pilots and flight crew members for psychoactive substances such as opioids & cannabis to ensure safe air travel.

Request a free sample copy or view report summary: https://www.grandviewresearch.com/industry-analysis/drug-testing-market

Drug Testing Market Report Highlights

By product type, the consumables segment dominated the market in 2023, owing to its repetitive use to conduct substance abuse screening

Based on sample type, the urine samples segment accounted for the largest revenue share in 2023, as it is the most common method of sample collection

Increased unemployment and economic crisis due to the Covid-19 pandemic has made people more susceptible to substance abuse, thus created lucrative opportunities in the market

The legalization of marijuana for medicinal as well as recreational use in several countries is anticipated to change the current scenario and may create demand for innovative testing solutions

Stringent privacy rights in some countries are likely to limit substance abuse testing at workplaces, impeding market growth

In Asia Pacific, the market is expected to witness lucrative growth over the forecast period as a result of the growing demand for substance abuse testing from emerging economies, such as China and India

Drug Testing Market Segmentation

Grand View Research has segmented the global drug testing market based on product, sample, drug, end-use, and region:

Drug Testing Product Outlook (Revenue, USD Million, 2018 - 2030)

Consumables

Instruments

Rapid Testing Devices

Services

Drug Testing Sample Outlook (Revenue, USD Million, 2018 - 2030)

Urine Samples

Oral Fluid Samples

Hair Samples

Other Samples

Drug Testing Drug Outlook (Revenue, USD Million, 2018 - 2030)

Alcohol

Cannabis/Marijuana

Cocaine

Opioids

Amphetamine & Methamphetamine

LSD

Others

Drug Testing End-use Outlook (Revenue, USD Million, 2018 - 2030)

Drug Testing Laboratories

Workplaces

Hospitals

Others

Drug Testing Regional Outlook (Revenue in USD Million, 2018 - 2030)

North America

Europe

Asia Pacific

Latin America

Middle East and Africa

Regional Insights

North America drug testing market dominated and accounted for a 39.5% share in 2023. This high share is attributable to the local presence of key global market players, such as Bio-Rad Laboratories, Laboratory Corporation of America Holdings, Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd. and others. Moreover, the growth of the drug testing market in North America can majorly be attributed to the increasing incidence of abuse, stringent government regulations, and active screening programs. The governments are actively engaged in controlling the consumption of hazardous drugs to minimize the cost burden associated with it. In addition, the authorities are focusing on formulating new policies. For instance, in September 2023, San Francisco Human Services Agency (SFHSA) announced a new initiative that would need people suffering from substance use disorder who wish to gain access to county funds to enroll in treatment and services.

List of Key Players in Drug Testing Market

Quest Diagnostics Incorporated

Abbott

F. Hoffmann-La Roche Ltd.

Quidel Corporation

Thermo Fisher Scientific, Inc.

Siemens Healthcare GmbH

Bio-Rad Laboratories, Inc.

Agilent Technologies, Inc.

Laboratory Corporation of America Holdings

Clinical Reference Laboratory, Inc.

Cordant Health Solutions

Browse Full Report: https://www.grandviewresearch.com/industry-analysis/drug-testing-market  

[healthcaremarketanalysis]

Laboratory Information Management System (LIMS) Market Worth $3.8 billion by 2029

The size of global laboratory information management system market in terms of revenue was estimated to be worth $2.1 billion in 2024 and is poised to reach $3.8 billion by 2029, growing at a CAGR of 12.9% from 2024 to 2029. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights derived from conferences and webinars, identification of key stakeholders, and a nuanced understanding of market purchasing dynamics.

Download an Illustrative overview:

Browse in-depth TOC on "Laboratory Information Management System (LIMS) Market"

200 - Tables

40 - Figures

400 - Pages

Driver: Growing use of LIMS to comply with stringent regulatory requirements Automating routine lab procedures with the help of devoted workstations and software improves lab productivity and enables individual researchers to focus on important tasks. This is a major factor driving the adoption of informatics in the pharmaceutical and biotechnology industry. According to a study, error rates for fully automated operations vary from 1–5%, those for semi-automated operations range from 1–10%, while those for manual operations vary from 10–30% (Source: Journal of Lab Automation).

Restraint: High maintenance and service costs The high maintenance and service costs associated with LIMS solutions can significantly impact the growth of the LIMS market. While LIMS solutions offer numerous benefits in terms of streamlining laboratory workflows and improving data management, the costs involved in maintaining and servicing these systems can pose challenges for organizations, especially smaller laboratories or those with limited budgets.

Opportunity: Growing use of LIMS in cannabis industry

Medical cannabis has demonstrated effectiveness in a range of medical applications, including alleviating chemotherapy-induced nausea, stimulating appetite in AIDS patients, managing muscular spasms in multiple sclerosis patients, and reducing intraocular pressure in glaucoma patients. Due to these potential health benefits, numerous countries and states have legalized medical cannabis. This legalization has spurred the emergence of cannabis testing laboratories, which offer quality control services for the medical cannabis industry.

Challenge: Dearth of trained professionals With the growing trend towards digitization, the healthcare industry's adoption of IT solutions has surged significantly over the past decade. This has led to an increased demand for skilled IT professionals and individuals with advanced analytical capabilities to interpret data from CIT solutions, including LIMS. However, a substantial gap exists between the supply and demand for these skilled professionals, which may hinder the adoption of LIMS, especially in pharmaceutical, biotechnology, and medical device companies, which represent over 50% of the LIMS market.

North America dominated the laboratory information management system industry in 2023 The laboratory information management system market is segmented into five major regions- North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for the largest share of the Laboratory Information Management Systems (LIMS) market. This growth is propelled by factors such as the region's high per-capita healthcare expenditure, continuous innovation in laboratory technologies, and the integration of LIMS with Enterprise Resource Planning (ERP) and Clinical Decision Support (CDS) systems. The accessibility to advanced healthcare facilities and the increasing number of biobanks further contribute to the expanding LIMS market in North America. Additionally, the emphasis on quality control, regulatory compliance, and the adoption of digitization in laboratory processes are driving the demand for LIMS solutions in the region. Overall, the North American market's robust growth in the LIMS sector can be attributed to a combination of technological advancements, regulatory requirements, and the healthcare industry's evolving needs.

Prominent companies in this market include LabWare (US), LabVantage Solutions Inc. (US), Thermo Fisher Scientific Inc. (US), Agilent Technologies (US), LabLynx, Inc. (US), Dassault Systèmes (France), Labworks LLC (US), Autoscribe Informatics (a wholly owned subsidiary of Autoscribe Limited) (US), Accelerated Technology Laboratories (ATL) (US), CloudLIMS (US), Computing Solutions, Inc. (US), GenoLogics Inc. (an Illumina Company) (Canada), Siemens (Germany), Novatek International (Canada), Ovation (US), Clinsys (US), Eusoft Ltd. (Italy), Caliber International (US), LABTrack (US), Agilab SAS (US), Agaram Technologies (India), and AssayNet Inc. (Canada), Blaze Systems Corporation (US), and LabLogic Systems Limited (UK).

Recent Developments of the Laboratory Information Management Systems (LIMS) Industry:

In February 2024, Labware has inaugurated its newest office in Seoul, Korea and established LabWare Korea Co., Ltd. This office will provide localized support, training, and implementation services to LabWare's growing customer network in Korea. Staffed by experienced LIMS professionals, the office aims to strengthen LabWare's foothold in the Asia-Pacific region by offering tailored solutions to meet the unique needs of Korean organizations.

In January 2024, STARLIMS has launched Life Sciences for Public Health (LPH) 1.0, a LMS tailored for the Public Health sector. Featuring HTML5 browser-based technology, it signifies a significant advancement, promising a modernized user interface and enhanced functionalities. The release marks the beginning of a comprehensive, multi-year product roadmap aiming to elevate user experience and innovation in the Public Health LIMS market.

In Novemeber 2023, LabWare (US) partnered with Körber (US). This partnership was carried to seamlessly integrate capabilities between LabWare's Laboratory Information Management System (LIMS) and Körber's Manufacturing Execution System (MES) - PAS-X.

In October 2022, LabVantage Solutions, Inc. (US) and Biomax Informatics AG (Germany) finalized their merger agreement, with the goal of elevating scientific data contextualization, expediting product development, and delivering innovative capabilities for the life science and bio-manufacturing industries.

Content Source:

[helthcareheven]

Exploring CBD's Impact: Market Trends and Consumer Insights

The cannabis sativa plant contains over 100 cannabinoids, with cannabidiol (CBD) and tetrahydrocannabinol (THC) being the primary active components extracted and isolated for commercial use. CBD is a non-intoxicating cannabinoid found in cannabis and hemp plants. It has been used to treat various medical conditions such as chronic pain, nausea, anxiety, depression and insomnia due to its antioxidant and neuroprotective properties. CBD products are available in various forms such as oils, tinctures, gels, creams and soft gels. The need for CBD products has been increasing owing to the legalization of cannabis derivatives and awareness about the therapeutic benefits of CBD in managing medical conditions without the psychoactive effects of THC.

The global cannabidiol market is estimated to be valued at US$ 323.23 million in 2024 and is expected to exhibit a CAGR of 4% over the forecast period of 2023 to 2030. Key Takeaways Key players operating in the cannabidiol market are Geographically, the anesthesia gas evaporator market has been classified into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America hold the major share due to higher per capita income and technological advancement. Also, rise in health concerns among the people formed a major factor for rise in surgical and minimally invasive procedures in the U.S. According to American Society of Plastic Surgeons (ASPS), around 15.9 million surgical and minimally-invasive cosmetic procedures performed in the U.S. in 2015 which showed a 2% increase over 2014. The increasing legalization of cannabis and rising awareness about the therapeutic properties of CBD provide lucrative growth opportunities. Many countries and states have legalized the use of CBD products derived from hemp containing less than 0.3% of THC. Around 7.8 million Americans are estimated to have used legal CBD in 2020 according to Brightfield Group. Key companies are focusing on geographical expansion to penetrate developing regions having lenient CBD regulations such as Asia Pacific and Latin America. Companies are investing in new product development and acquisitions to consolidate their market share globally. Market Drivers Increasing legalization of cannabis derivatives: Legalization of cannabis and THC/CBD-containing hemp derivatives for medical and recreational adult use in various countries is expected to fuel the CBD market growth over the forecast period. This alleviates the restrictions over processing, distribution and retail of CBD-infused products. Awareness about therapeutic properties: With increased scientific research validating the therapeutic effects, consumers are gaining awareness about CBD’s benefits in easing symptoms of medical conditions such as epilepsy, multiple sclerosis and chronic pain. This drives its demand for both medical and wellness applications. Market Restraints Stringent regulations over CBD content: Distributors and manufacturers face challenges regarding varying regulations defining the maximum permissible levels of THC in CBD derivatives across different regions. Products violating these norms are at risk of facing legal consequences. Limited clinical evidence and research: More extensive clinical studies are still required to validate the therapeutic efficacy, safety, optimal dosage and potential drug interactions. This hinders the widespread adoption of CBD till now. Segment Analysis The cannabidiol market can be segmented based on product type into hemp-derived CBD and marijuana-derived CBD. Presently, the hemp-derived CBD segment dominates the market as it is legal in most parts of the world. Hemp-derived CBD is easily available, affordable, and has various therapeutic applications like reducing inflammation, pain, and anxiety. This wide demand and legal acceptance has made hemp-derived CBD the dominant segment currently. Global Analysis North America holds the largest share in the global cannabidiol market. Higher healthcare spending, presence of major players, and growing legal acceptance of marijuana drive the North America cannabidiol market. Within North America, the U.S. dominates due to presence of major companies and favorable laws allowing CBD products. The Asia Pacific region is expected to grow the fastest during the forecast period due to rising disposable incomes, growing health awareness, and relaxation of laws regarding CBD items in certain countries. China, India, Japan, and Australia are major markets in Asia Pacific supporting the regional growth of the cannabidiol industry. Rapidly developing healthcare sector also assists market expansion across Asia Pacific.

[marketblogresearch]

Cannabis Cultivation Market Drivers, Sales, Profits & Analysis by Forecast to 2030

Investors are expected to receive business-oriented market insights from The Insight Partners "Overview of Cannabis Cultivation Market Share, Size, and 2030" | market study. This study incorporates forecasts for the future market in addition to operational variables. This research addresses a variety of possibilities accessible for Cannabis Cultivation market participants in addition to drivers and obstacles. Valid facts included in this research have been framed using both primary and secondary research approaches.

Cannabis Cultivation Market research delves deeply into many categories to provide a thorough perspective for both seasoned players and recent arrivals. Companies may guarantee they have a competitive edge by using this market research to have a better perspective and knowledge of the target audience. Before making significant investments, businesses must have a firm understanding of the market. It makes financial sense to allocate a modest portion of your company's expenditure to reliable market research.

Firms must take an open-minded attitude in light of the competitive landscape discussed in this research. Companies may utilize the objective insights provided by this market research to identify their strengths and limitations. Companies that can capitalize on the fresh ideas gained from competition analysis will have an edge in moving forward.

A market research report, which contains proof of market research and provides the best opportunity for businesses to fulfill their objectives, might serve as the cornerstone of your business strategy.

Key objectives of this research are:

Global Cannabis Cultivation Market Insights- Market Share, Market Size, and CAGR

To Examine Drivers, Challenges, and Opportunities in Cannabis Cultivation Market

To offer competitive strategic insights that help businesses ace the game

To offer an actionable market recommendation

To brief on the impact of COVID-19 and present an account of strategic responses businesses can plan.

To analyze the Cannabis Cultivation market benchmarks.

COVID-19 Impact Analysis

Halting the operations temporarily, an epidemic of COVID-19 influenced on revenues of key Cannabis Cultivation market players. This section presents details on the range of responses businesses have to pandemic impacts and assists companies in developing post-pandemic strategies. Moving further, this chapter offers insights into supply-demand parameters for businesses to rejoin the market.

To Summarize the Offerings-

Market Forecast- Coverage- Market Size, Share, and CAGR | Forecast by 2030

Market Scope– Aim of the research, A glance at key chapters

Market Dynamics- Drivers, Challenges, Regional Trends, and Market Opportunities

Market Segmentation – Product, Application, End-use Industries, and Regional Growth Prospects.

Market Players – Key Market Players and Strategies

Recent Developments and Innovation in Cannabis Cultivation Market

Covid-19 Analysis- Industry Landscape During and Post-Pandemic.

Regional Framework- Key Regional Markets, Growth Projections

Market SegmentationBased on By Product this market is categorized further into- :

Buds

Oils

Tinctures

Based on Applications this market is categorized further into- :

Medical

Recreational

Industrial Hemp

Based on Geography this market is categorized further into- :

North America

Europe

Asia Pacific

and South and Central America

Key regions Cannabis Cultivation Market Research Report:

North America (U.S., Canada, Mexico)

Europe (U.K., France, Germany, Spain, Italy, Central & Eastern Europe, CIS)

Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific)

Latin America (Brazil, Rest of Latin America)

The Middle East and Africa (Turkey, GCC, Rest of the Middle East and Africa)

Rest of the World

Avi

Senior Market Research expert at The Insight Partners

[omkarpatel]

Hemp Oil is estimated to witness high growth owing to relaxation in regulations

Hemp oil or Cannabidiol (CBD) oil is derived from the leaves, flower clusters, and stalks of mature hemp plants. It is known for medicinal purposes and contains antioxidants, anti-inflammatory compounds, and neuroprotective effects. CBD oil is used for reducing pain, soothing anxiety and stress, reducing inflammation, and promoting better sleep. The global hemp oil market has gained immense popularity due to the awareness about its health benefits. The global Cannabidiol Market is estimated to be valued at US$ 323.23 Mn in 2023 and is expected to exhibit a CAGR of 4.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Opportunity: The relaxation in regulations around the production, distribution and sale of hemp oil and its derivatives is expected to drive the market growth. Several countries and regions have legalized the cultivation and use of industrial hemp for commercial use which has opened lucrative opportunities for market players. With more countries and states adopting a lenient policy approach towards medicinal and recreational marijuana use, the cannabidiol market is poised to witness significant growth over the forecast period. This emerging regulatory environment is expected to attract new market entrants and propel innovation. Increased research and development activities around phytocannabinoids will further support the market expansion. Porter's Analysis Threat of new entrants: The threat of new entrants is low as Cannabidiol market is consolidated with established brands. Significant capital is required to enter and gain foothold in this market. Bargaining power of buyers: The bargaining power of buyers is high due to availability of alternative products. Buyers can easily switch to substitutes if product quality or pricing is not up to the mark. Bargaining power of suppliers: The bargaining power of suppliers is moderate as quality raw materials are required and suppliers have established relationships with key players. Threat of new substitutes: Threat of new substitutes is high as players are continuously researching and developing new delivery formats like edibles, beverages, topicals etc. Competitive rivalry: The competitive rivalry is high due to presence of established brands fighting for market share. Players compete on product quality, pricing and innovation. SWOT Analysis Strength: Growing research proving medical benefits of Cannabidiol, Increasing legalization leading to rise in adoption. Weakness: Regulatory uncertainty in some regions, knowledge gap regarding appropriate dosage. Opportunity: Emerging markets in Asia Pacific and Latin America, New product formats attracting first time users. Threats: Negative social perception, Strict norms hampering innovation. Key Takeaways The global Cannabidiol market is expected to witness high growth during the forecast period of 2023 to 2030. The market size for 2023 is $323.23 Mn and market is expected to grow at a CAGR of 4.0% during the forecast period. Regional analysis: North America dominates the global Cannabidiol market currently due to favourable regulatory environment and growing cannabis legalization measures. The US holds the major market share in the region. Asia Pacific is expected to be the fastest growing region during the forecast period due to initiatives by governments to legalize medical cannabis in countries like Thailand, South Korea, Australia etc. Key players: Key players operating in the Cannabidiol market are ENDOCA, Cannoid, LLC, Medical Marijuana, Inc., Folium Biosciences, Elixinol, NuLeaf Naturals, LLC, Isodiol International, Inc.,Pharmahemp d.o.o. Players compete on the basis of products quality, consistency, potency and R&D investment for new product development.

[adhk1234]

CBD skincare product Market Future Prospects: Industry Predictions and Expansion Strategies

The global CBD skincare product market is experiencing remarkable growth, driven by increasing consumer awareness of the benefits associated with CBD-infused personal care items. Valued at USD 2,297.8 million in 2023, the market is projected to reach USD 22,191.0 million by 2032, exhibiting a compound annual growth rate (CAGR) of 28.7% over the forecast period 2024-2032.

Market Segmentation:

The CBD skincare product market is segmented based on product type, distribution channel, source, and region.

By Product Type:

Oils

Creams & Moisturizers

Masks & Serums

Cleansers

Others

By Distribution Channel:

Online Retailers

Supermarkets/Hypermarkets

Specialty Stores

Pharmacies

Others

By Source:

Hemp-derived CBD

Marijuana-derived CBD

Get Free Sample Report @ https://www.snsinsider.com/sample-request/1023

Regional Analysis:

North America currently dominates the CBD skincare product market, attributed to increased cannabis sales and cultivation, particularly for addressing serious skin conditions. The region's proactive approach to cannabis legalization and consumer acceptance has further propelled market growth. Europe and the Asia-Pacific regions are also witnessing significant growth, driven by rising consumer awareness and the gradual legalization of CBD-infused products.

Key Players

Cannuka, LLC

Earthly Body

Josie Maran

Kapu Maku LLC. (Populum)

Kiehl’s

LEEF

Lord Jones

Sephora USA, Inc.

The CBD Skincare Co

Kush Creams

Isodiol International Inc.

Endoca 

Kapu Maku LLC.

LEEF organics

Vertly

Lily CBD

Kana Skincare 

L’Oréal SA

Elixinol

Green Growth Brands

Herbivore botanicals

IldiPekar Skin Care & Spa

Isodiol International Inc

Josie Maran Cosmetics

CBD for Life and others.

Key Highlights:

Growing consumer demand for natural and chemical-free skincare solutions is driving the market.

Major retailers, including Sephora and Ulta Beauty, are featuring CBD skincare products, enhancing accessibility for consumers.

Innovative product launches by companies such as Bombay Hemp Company and Avicanna Inc. are expanding the market.

Future Outlook:

The CBD skincare product market is poised for substantial growth, driven by ongoing research and product innovation. As consumers increasingly seek natural and therapeutic skincare solutions, CBD-infused products are expected to gain further traction. The trend towards legalization and acceptance of CBD across various regions will also play a crucial role in shaping the market's future landscape.

Conclusion:

The global CBD skincare product market is on a robust growth trajectory, with significant opportunities emerging across various segments and regions. Stakeholders, including manufacturers, retailers, and investors, are well-positioned to capitalize on the evolving consumer preferences towards CBD-infused skincare solutions.

Contact Us: Jagney Dave - Vice President of Client Engagement Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)

Other Related Reports:

Bone Densitometer Market Size

Tissue Diagnostics Market Share

Bone Densitometer Market Size

[the-emerald-standard]

Cannabis Products Testing Services Market Set to Experience Explosive Growth by 2029 - CannaSafe, SGS Canada, and ACS Lab Lead the Way

Cannabis Products Testing Services Market to Witness Huge Growth by 2029

The global cannabis products testing services market is expected to witness significant growth in the coming years, according to a new report from Benzinga. The report, titled “Cannabis Products Testing Services Market to Witness Huge Growth by 2029 -CannaSafe, SGS Canada, ACS Lab”, provides an in-depth analysis of the market, highlighting the key drivers and opportunities for growth.

The report states that the global cannabis products testing services market is anticipated to grow at a CAGR of 8.5% during the forecast period (2020-2029). This growth is attributed to the increasing demand for cannabis products, the rising number of regulations and standards, and the growing awareness about the safety of cannabis products.

The report further states that the market is segmented into application, type, and region. By application, the market is divided into medical and recreational. By type, the market is divided into potency testing, pesticide testing, heavy metal testing, and microbial testing. By region, the market is divided into North America, Europe, Asia Pacific, and Rest of the World.

The report also provides an in-depth analysis of the key players in the market, including CannaSafe, SGS Canada, and ACS Lab. CannaSafe is a leading provider of cannabis testing services in North America, offering a wide range of services including potency testing, pesticide testing, heavy metal testing, and microbial testing. SGS Canada is a leading provider of cannabis testing services in Europe, offering a wide range of services including potency testing, pesticide testing, heavy metal testing, and microbial testing. ACS Lab is a leading provider of cannabis testing services in Asia Pacific, offering a wide range of services including potency testing, pesticide testing, heavy metal testing, and microbial testing.

Key Takeaways:

The global cannabis products testing services market is expected to witness significant growth in the coming years.

The market is segmented into application, type, and region.

The key players in the market include CannaSafe, SGS Canada, and ACS Lab.

The report concludes by briefly and lightly highlighting the advantages of hiring ACS Lab, an industry trusted testing and compliance partner for hemp and cannabis. ACS Lab provides comprehensive testing services for hemp and cannabis products, ensuring compliance with the highest standards of safety and quality. To learn more about the services offered by ACS Lab, click here.

Source: news-webmaster@google.com

[alliedcreation]

CBD Skin Care Market Size Worth USD 3,484.00 Million By 2026 | Growth Rate (CAGR) of 24.80%

"CBD Skin Care Market by Product Type, and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2019–2026," The global CBD skin care market size was valued at $633.6 million in 2018 and is anticipated to reach $3,484.00 million by 2026, with a CAGR of 24.80% during the forecast period. The global CBD oil segment was valued at $219.0 million in 2018 and is anticipated to reach $1,134.0 million by 2026, with a CAGR of 24.00% during the forecast period.

Get Exclusive Sample Report: @ https://www.alliedmarketresearch.com/request-sample/6291

Legalization of cannabis and cannabis derivatives including cannabidiol (CBD) and hemp oil have increased the popularity of these ingredients among wellness and personal care products industry. Consumers are looking for CBD-infused products with natural active ingredients over other chemical based cosmetics. As a result, the cosmetics and personal care industries are expected to witness significant growth in cosmetic product infused with CBD and hemp oil. Some the leading cosmetic brands are already offering or experimenting in CBD based skin care products. Upscale retailers and some private label brands have already launched some products, which show the influence of CBD in mainstream cosmetic market. This trend is expected to gain traction among the global CBD skin care market players in few years.

The producers of CBD-based cosmetic products are facing certain challenges due to controversial nature of cannabis-derived ingredients in cosmetic products. Manufacturers need to take more precautions during manufacturing operation to avoid cross-contamination between CBD and non-CBD products. As a result, many companies are planning to run a separate production line for CBD skin care products to avoid cross-contaminations.

The CBD skin care market is segmented on the basis of product type, source, distribution channel, and region. By product type, it is categorized into oils, lotion & creams, masks & serums, bath & soaps, and others. CBD oil is one of the key ingredients in every CBD skin care product. The ready availability and convenient manufacturing processes have made CBD oil as one of the lucrative segments for new entrants. Small scale cosmetic manufacturers are mainly focusing toward CBD oil production due to varied applications in wellness and cosmetic. By form, it is categorized into Hemp and Marijuana. By distribution channel, it is categorized into departmental stores, e-commerce, hypermarkets/supermarkets, retail pharmacies, and others. Rise in penetration of internet among generation Z and novel cost benefits associated with E-commerce shopping are responsible for revenue growth of the e-commerce segment in the CBD skin care market. The global E-commerce segment was valued at $113.2 million in 2018 and is anticipated to reach $728.2 million by 2026, with a CAGR of 27.40% during the CBD skin care market forecast period.

Inquiry Before Buying @ : https://www.alliedmarketresearch.com/purchase-enquiry/6291

Region-wise, CBD skin care market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, Spain, Italy, and Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South Korea, and Rest of Asia-Pacific), and LAMEA (the Middle East, Latin America, and Africa). Premium nature of CBD infused skin care products and a touch of natural ingredients to the product offerings are increasing the popularity of CBD infused skin care products among consumers from the North America and Europe regions. Furthermore, increase in awareness toward medicinal and cosmetic benefits of cannabis coupled with active support from regulatory authority is expected to provide revenue boost to CBD skin care market in the North America and Europe regions.

Key Findings of the Study:

The CBD skin care oils segment is expected to grow at a CAGR of 24.00% during the forecast period.

North America is anticipated to dominate the CBD skin care market share, registering a CAGR of 24.3% during the forecast period.

Asia-Pacific is projected to exhibit exponential growth throughout 2026, registering the highest of CAGR 26.7% during the forecast period.

The departmental stores distribution segment is anticipated to dominate the global CBD skin care market analysis, with a CAGR of 23.5% during the forecast period.

The E-commerce segment is estimated to grow at a CAGR of 27.4% during the forecast period.

The key players operating in the global CBD skin care industry include Kiehl’s LLC, Cannuka LLC, Leef Organics, Medical Marijuana Inc., Lord Jones, Kapu Maku LLC, VERTLYBALM, Elixinol Global Limited, Fab CBD Company, and Endoca LLC. Other key players identified in the value chain are L’Oreal, Varm Cosmo, L’Eela, Apothecanna, Charlotte’s Web Holdings, Kana Skincare, Josie Maran Cosmetics, Cronos Group, CBD Biotech, and Estee Lauder.

LIMITED-TIME OFFER - Buy Now & Get Exclusive on this Report @ https://www.alliedmarketresearch.com/checkout-final/403d34508dd4c3e90af1ef760ef21930

[rohans18]

Cannabis Pharmaceutical Market Trends, Share, Competitive Dynamics, Demand - Forecast 2028

Global Cannabis Pharmaceutical Market, By Product Type (Capsules, Concentrates, Edibles, and Other), Drugs (Epidiolex, Marinol, Cesamet, Sativex, Others), Compound Type (Tetrahydrocannabinol (THC), Cannabidiol (CBD), and Balanced THC & CBD), Application (Inflammation, Chronic Pain, Epilepsy, Sleep Disorders, Anorexia, Schizophrenia, Others), End-Users (Clinic, Hospital, others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.

An expert team performs systematic, object-oriented and complete market research study to provide the facts associated with any subject in the field of marketing via Cannabis Pharmaceutical marketing report. The report has a lot to offer to both established and new players in the Cannabis Pharmaceutical industry with which they can completely understand the market. SWOT analysis and Porter’s Five Forces analysis methods are used wherever applicable, while generating this report. One of the most important parts of an international Cannabis Pharmaceutical market report is competitor analysis with which businesses can estimate or analyse the strengths and weaknesses of the competitors.

Key Players

The major players covered in the global cannabis pharmaceutical market report are GW Pharmaceuticals plc., Bausch Health Companies Inc., AbbVie Inc., Insys Therapeutics, Inc., Corbus Pharmaceuticals Holdings, Inc., Teva Pharmaceutical Industries Ltd., Avicanna Inc., Solvay and Cannabics Pharmaceuticals, among other domestic and global players.  Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Browse More Info @ https://www.databridgemarketresearch.com/reports/global-cannabis-pharmaceutical-market

With the help of credible Cannabis Pharmaceutical market analysis report, businesses can make out the reaction of the consumers to an already existing product in the market. The report includes estimations of recent state of the market, CAGR values, market size and market share, revenue generation, and necessary changes required in the future products. A wide-ranging competitor analysis helps build superior strategies of production, improvement in certain product, its advertising or marketing and promotion for the business. Exhaustive and comprehensive market study performed in the wide ranging Cannabis Pharmaceutical market report offers current and forthcoming opportunities that put light on the future market investment.

Key questions answered in the report:

Which product segment will grab a lion’s share?

Which regional market will emerge as a frontrunner in coming years?

Which application segment will grow at a robust rate?

Report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in the Cannabis Pharmaceutical Market.

Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.

Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.

Table Of Content

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03:  Global Market

Part 04: Global Market Size

Part 05: Global Market Segmentation By Product

Part 06: Five Forces Analysis

 More Reports:

Diuretic Drugs Market

Patient Engagement Technology Market

Healthcare Business Intelligence Market

Chinese Hamster Ovary cells (CHO) Market

Anti-cancer Drug Market

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: sales@databridgemarketresearch.com

[reportsneww]

Neurological Biomarkers Market is anticipated to exhibit a CAGR of 11.9% from 2022 to 2030

Newark, New Castle, USA – Growth Plus Reports’ most recent study examines the Global Neurological Biomarkers Market’s production, prospective uses, demand, key companies, and SWOT analysis.

You may get insights into the TOC, and Statistics for essential facts, information, trends, and competitive landscape information.

Download Free Sample Report Now @ https://www.growthplusreports.com/inquiry/request-sample/neurological-biomarkers-market/8040

The following are the leading companies in the Global Neurological Biomarkers market:

Abbott Laboratories Inc.

Quanterix Corporation

Thermo Fisher Scientific Inc.

Qiagen NV

Bio-Rad Laboratories Inc.

Merck KGaA

Banyan Biomarkers Inc.

Johnson & Johnson

ACOBIOM

Myriad Genetics Inc.

DiaGenic ASA

Olink Biosciences

Growth Plus Reports studies the key trends in each category and sub-segment of the Neurological Biomarkers market, along with Global and regional projections from 2023 to 2031. Our research splits the market into product type and application segments.

SEGMENTATION

GLOBAL NEUROLOGICAL BIOMARKERS MARKET – ANALYSIS & FORECAST, BY TYPE

Genomic

Metabolomic

Proteomic

Imaging

Others

GLOBAL NEUROLOGICAL BIOMARKERS MARKET – ANALYSIS & FORECAST, BY APPLICATION

Alzheimer’s Disease

Parkinson’s Disease

Multiple Sclerosis

Others

GLOBAL NEUROLOGICAL BIOMARKERS MARKET – ANALYSIS & FORECAST, BY END-USER

Hospitals & Laboratories 

Independent Diagnostic Centers 

Research Organizations 

Others

For More Information or Query or Customization visit: https://www.growthplusreports.com/inquiry/customization/neurological-biomarkers-market/8040

Companies may utilize Neurological Biomarkers market report to get insights on market variables and any restraints that may affect the manufacturing of their product. Companies that are expanding abroad require thorough Global market research that includes real market data to assist with their marketing strategy. This Global market Neurological Biomarkers industry study analyzes important market dynamics and provides in-depth information and statistics to help companies flourish. This research report on the Neurological Biomarkers market takes advantage of advanced and professional approaches such as SWOT analysis and GRG Health’s unique GrowthMIX strategy.

This report is useful in addressing various essential issues for market participants, while also supporting them in making investments and leveraging the market opportunities.

Neurological Biomarkers Market TOC: https://www.growthplusreports.com/report/toc/neurological-biomarkers-market/8040

Market segment by Region/Country including: –

-North America (United States, Canada and Mexico) -Europe (Germany, UK, France, Italy, Russia and Spain etc.) -Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.) -South America (Brazil, Argentina and Colombia etc.) -Middle East and Africa (South Africa, UAE and Saudi Arabia etc.)

QUICK BUY: https://www.growthplusreports.com/checkout-8040

Browse Latest Healthcare Reports:

Cannabis Drugs Market

Sterilization Wrap Market

Foley Catheters Market

Thrombin Market

Trauma Implants Market

Urinary Drainage Bags Market

Genetic Disease Diagnostics Market

Veterinary Diagnostics Market

Intraoral Scanners Market

Immunodiagnostics Market

Neurodegenerative Disease Drugs Market

Pet Insurance Market

Contact Us:

Manan Sethi Director, Market Insights Email: sales@growthplusreports.com Phone no: +1 888 550 5009 Web: https://www.growthplusreports.com/

About Us Growth Plus Reports is part of GRG Health, a Global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association). Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success. We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020.”